Citation
(2009), "Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis", Clinical Governance: An International Journal, Vol. 14 No. 4. https://doi.org/10.1108/cgij.2009.24814dae.005
Publisher
:Emerald Group Publishing Limited
Copyright © 2009, Emerald Group Publishing Limited
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 14, Issue 4
M. Briel, I. Ferreira-Gonzalez, J.J. You, J. Karanicolas, E.A. Akl, P. Wu, et al.,BMJ,2009,Vol. 38,p. b92,
This review and meta-regression concluded that increasing the amount of high density lipoprotein cholesterol with lipid modifying treatment did not reduce the risk of coronary heart disease events and death or all-cause deaths. Results supported recommendations for reducing low density lipoprotein cholesterol with lipid-modifying interventions. This was a well-conducted review and the authors’ conclusions were likely to be reliable.